Save your place

Sign in to WhoBought

Please try again later.

Cathie Wood's Regeneron Pharmaceuticals, Inc. (REGN) position

Not anymore: Cathie Wood fully exited REGN in Q1 2026. The position peaked at $577M in Q1 2021.
View full portfolio →
Value at exit
$85K
Shares at exit
110
Est. average buy price (i)
$494.24
est. since Q1 2021
Quarter-end price
$771.66

Estimated trade prices

Average price in quarters with purchases
$687.82
Average prices in quarters with sales
  • Q4 2025: $679.43 (12K shares sold)
  • Q3 2025: $565.41 (464 shares sold)
  • Q2 2025: $558.13 (1K shares sold)
  • Q4 2024: $839.22 (2K shares sold)
  • Q3 2024: $1,112.86 (714 shares sold)
  • Q2 2024: $969.40 (2K shares sold)
  • Q1 2024: $950.88 (10K shares sold)
  • Q4 2023: $823.50 (9 shares sold)
  • Q3 2023: $785.91 (5K shares sold)
  • Q2 2023: $771.00 (1K shares sold)
  • Q1 2023: $754.21 (462 shares sold)
  • Q4 2022: $737.86 (3K shares sold)
  • Q3 2022: $629.39 (19K shares sold)
  • Q2 2022: $650.01 (2K shares sold)
  • Q1 2022: $632.65 (15K shares sold)
  • Q4 2021: $614.83 (355K shares sold)
  • Q3 2021: $620.82 (285K shares sold)
  • Q2 2021: $506.62 (506K shares sold)

REGN price vs Wood's position

1Y 3Y 5Y MAX
Dates
$200$500$1,000$1,50020192020202120222023202420252026Sold 506K shares (41.5%) · Q2 2021. Average closing price $506.62 · Price range $472.80–$558.54506KsharessoldSold 285K shares (40.0%) · Q3 2021. Average closing price $620.82 · Price range $574.03–$680.96285KsharessoldSold 355K shares (83.0%) · Q4 2021. Average closing price $614.83 · Price range $543.48–$670.97355KsharessoldSold 15K shares (20.9%) · Q1 2022. Average closing price $632.65 · Price range $595.12–$698.4315KsharessoldSold 2K shares (3.4%) · Q2 2022. Average closing price $650.01 · Price range $548.35–$738.842KsharessoldSold 19K shares (33.8%) · Q3 2022. Average closing price $629.39 · Price range $573.97–$724.3219KsharessoldSold 3K shares (7.8%) · Q4 2022. Average closing price $737.86 · Price range $705.89–$766.393KsharessoldSold 462 shares (1.4%) · Q1 2023. Average closing price $754.21 · Price range $680.49–$826.97462sharessoldSold 1K shares (4.0%) · Q2 2023. Average closing price $771.00 · Price range $700.03–$830.351KsharessoldSold 5K shares (14.0%) · Q3 2023. Average closing price $785.91 · Price range $692.45–$844.375KsharessoldSold 9 shares (under 0.1%) · Q4 2023. Average closing price $823.50 · Price range $775.18–$881.709sharessoldSold 10K shares (34.3%) · Q1 2024. Average closing price $950.88 · Price range $902.69–$993.3510KsharessoldSold 2K shares (12.9%) · Q2 2024. Average closing price $969.40 · Price range $883.20–$1,071.192KsharessoldSold 714 shares (4.5%) · Q3 2024. Average closing price $1,112.86 · Price range $1,024.09–$1,201.76714sharessoldSold 2K shares (12.9%) · Q4 2024. Average closing price $839.22 · Price range $701.85–$1,046.912KsharessoldAdded 502 shares (3.8%) · Q1 2025. Average closing price $687.82 · Price range $634.14–$744.83502sharespurchasedSold 1K shares (7.9%) · Q2 2025. Average closing price $558.13 · Price range $483.07–$625.601KsharessoldSold 464 shares (3.7%) · Q3 2025. Average closing price $565.41 · Price range $534.91–$598.71464sharessoldSold 12K shares (99.1%) · Q4 2025. Average closing price $679.43 · Price range $557.73–$787.3212Ksharessold
Average closing price · filing quarter
$679.43
Price range · filing quarter
$557.73 – $787.32
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Exited −110 −$84K −100.0% 0 May 12, 2026
Q4 2025 Reduced −12K −$8.2M −99.1% 110 Feb 11, 2026
Q3 2025 Reduced −464 −$262K −3.7% 12K Nov 12, 2025
Q2 2025 Reduced −1K −$607K −7.9% 13K Jul 30, 2025
Q1 2025 Added +502 +$345K +3.8% 14K May 7, 2025
Q4 2024 Reduced −2K −$1.6M −12.9% 13K Feb 4, 2025
Q3 2024 Reduced −714 −$795K −4.5% 15K Oct 31, 2024
Q2 2024 Reduced −2K −$2.3M −12.9% 16K Jul 26, 2024
Q1 2024 Reduced −10K −$9.1M −34.3% 18K Apr 18, 2024
Q4 2023 Reduced −9 −$7K 0.0% 28K Jan 17, 2024
Q3 2023 Reduced −5K −$3.5M −14.0% 28K Oct 18, 2023
Q2 2023 Reduced −1K −$1.0M −4.0% 32K Jul 10, 2023
Q1 2023 Reduced −462 −$348K −1.4% 34K Apr 17, 2023
Q4 2022 Reduced −3K −$2.1M −7.8% 34K Jan 24, 2023
Q3 2022 Reduced −19K −$12M −33.8% 37K Oct 17, 2022
Q2 2022 Reduced −2K −$1.3M −3.4% 56K Jul 11, 2022
Q1 2022 Reduced −15K −$9.6M −20.9% 58K Apr 19, 2022
Q4 2021 Reduced −355K −$218M −83.0% 73K Jan 28, 2022
Q3 2021 Reduced −285K −$177M −40.0% 428K Nov 12, 2021
Q2 2021 Reduced −506K −$256M −41.5% 713K Aug 5, 2021
Q1 2021 First covered – – – 1.2M May 13, 2021
Data through Q1 2026 · filed May 12, 2026
21 grouped rows from 21 quarters

More Wood positions

Tesla, Inc.(TSLA)
$1.1B
8.2% of portfolio

Advanced Micro Devices, Inc.(AMD)
$540M
4.3% of portfolio

CRISPR Therapeutics AG(CRSP)
$538M
4.2% of portfolio

Shopify Inc.(SHOP)
$496M
3.9% of portfolio

Palantir Technologies Inc.(PLTR)
$444M
3.5% of portfolio

Tempus AI, Inc.(TEM)
$434M
3.4% of portfolio

Common questions

Does Cathie Wood own REGN?

Not currently. Cathie Wood fully exited REGN in Q1 2026, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Cathie Wood buy REGN?

Cathie Wood held REGN since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Cathie Wood sell REGN?

Yes. Cathie Wood reduced and then fully exited REGN by Q1 2026; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of REGN does Cathie Wood own?

None as of the latest filing: Cathie Wood has exited REGN. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Cathie Wood pay for REGN?

Cathie Wood began building the REGN position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.